Top Stories
Clairyon's COMPOSER model will draw on SEQSTER's patient records, lab results, genomics and wearable data to spot sepsis before patients are already in danger.
Guardant360 CDx can now be used as a blood-based companion diagnostic for Boehringer Ingelheim's Hernexeos, a targeted treatment for HER2-mutant advanced NSCLC.
The new system can identify more than 100 molecular subtypes of central nervous system tumours using standard tissue sections.
CEO Bradley Paddock said the company is ready to reach more patients after recent FDA clearances for seven-day wear and 1-unit dosing.
The Future Health Index 2026 found half of clinicians said AI increased their capacity to see patients, while 70% said clear processes for monitoring AI tools were not yet in place.
Conference News
Onera hPSG®, an end-to-end home polysomnography solution from Onera Health, will be prominently featured at SLEEP 2026. The medtech company will showcase its innovative technology at booth #600, prese...
RIYADH, Saudi Arabia, June 11, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) will highlight its practical applications of artificial intelligence during its partici...
GDANSK, Poland and MANCHESTER, England, June 11, 2026 /PRNewswire/ -- Sky Labs (CEO Jack ByungHwan Lee) announced on the 11th that it hosted exclusive symposiums at the 35th European Society of Hypert...
Research underscores the expanding role of sleep health in whole-person care SAN DIEGO, June 11, 2026 – Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing ...
New findings add to prior data showing Hi-C sequencing detects clinically important lymphoma rearrangements missed or not targeted by conventional FISHCARLSBAD, Calif.--(BUSINESS WIRE)-- Arima Genomic...
